Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD •...
Transcript of Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD •...
![Page 1: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/1.jpg)
Ventricular arrhythmias & sudden cardiac death
Carina Blomstrom Lundqvist
Dept Cardiology, Uppsala, Sweden
![Page 2: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/2.jpg)
www.escardio.org
2
European Heart Journal 2015 doi/10.1093/eurheartj/ehv316
• The European update of the 2006 European/ American Guidelines focusing on preventing SCD in patients with VA
• 87 pages document; 809 references; 74 peer reviewers
![Page 3: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/3.jpg)
www.escardio.org
Autopsy and molecular autopsy in sudden death victims
• ~ 50% of cardiac arrests occur in individuals without known heart disease.
• Every time a heritable disease is identified in a deceased individual, the relatives may be at risk of being affected and dying suddenly.
3
NEW!- DNA analysis should be
a fundamental component of post
mortem assessment in SD victims, especially in
young.
![Page 4: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/4.jpg)
www.escardio.org
Screening patients with suspected or known ventricular arrhythmias
4
Speaker
ECG
Holter
Event recorders
ILR – if conventional techniques fail
SAEG – diagnostic tool
Suspected ischemia or exercise induced VA
![Page 5: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/5.jpg)
www.escardio.org
Screening patients with suspected or known ventricular arrhythmias
5
Echo for LV function
![Page 6: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/6.jpg)
www.escardio.org
Screening patients with suspected or known ventricular arrhythmias
EP study
• does not contribute to identify high risk patients in HCM (Class III).
• not indicated in channelopathies, debated in BrS.
6
EP study- Post MI pats with arrhythmia
related symptoms- Syncope pats if suspected brady
or tachy arrhythmia
![Page 7: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/7.jpg)
www.escardio.org
Therapies for ventricular arrhythmias• Device therapy - Implantable cardioverter defibrillator
Meta-analysis of 3 trials (AVID, CIDS, CASH):
ICD therapy associated with 50% (95% CI:0.37-0.67, P=0.0001) reduction in arrhythmic mortality and 28% (95% CI:0.60-0.87, P=0.006) reduction in total mortality.
Moderately cost-effective.
7
Speaker
ICD for secondary prevention of SCD and VT
– Same Class I Recommendation
![Page 8: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/8.jpg)
www.escardio.org
Device therapy - Subcutaneous ICD
• Effective in preventing SD.
• Data on long-term tolerability and safety arelacking.
• Not suitable for patients who require bradycardia pacing, CRT or suffer from tachyarrhythmias that can be terminated by ATP.
8
NEW!May be considered as an ICD
alternative- venous access, infections, or
in young pats
![Page 9: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/9.jpg)
www.escardio.org
Device therapy - Wearable cardioverter defibrillator
• No prospective randomized trials.
• Many case series, & registries (manufacturer or independently) with successful use of WCD in a small proportion of pats at risk of potentially fatal VAs.
9
NEW!May be consideredin pats at transient risk for SCD but not
suitable for ICD
![Page 10: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/10.jpg)
www.escardio.org
Early after myocardial infarction
10
NEW!Re-assess LVEF 6-12 w post MI:
- Need for primary preventive ICD?
![Page 11: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/11.jpg)
www.escardio.org
Stable coronary artery disease after myocardial infarction with preserved EF
Re-assess LVEF 6-12 weeks after coronary revascularization - identify potential indications for primary prevention ICD.
11
![Page 12: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/12.jpg)
www.escardio.org
Interventional therapy - Catheter ablation
12
Upgrade!Catheter ablation for incessant VT & electrical storms
NEW!Catheter ablation after
1st episode of sust. VT in pats with IHD.
![Page 13: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/13.jpg)
www.escardio.org
Therapies for patients with LV dysfunction with or without heart failure- Primary prevention of sudden cardiac death
2 large trials: primary prevention of SCD by ICD in patients with HF and reduced LVEF.
• SCD-HeFT; NYHA II-III, EF < 0.35. Mortality decreased 23% and absolute by 7% with ICD after 5 yrs (from 29% -22%).
• MADIT II; Post MI, EF < 0.30. Mortality decreased 31%, and absolute by 6 %.
• Meta-analysis: 5 primary prevention trials;
CAT, AMIOVIRT, DEFINITE, SCD-HeFT, COMPANION.
13
ICD for primary prevention of SCD – Same Class I
Recommendation.
![Page 14: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/14.jpg)
www.escardio.org
14
This is a slight “change” from ESC HF GL 2012, which said:ICD therapy is not indicated in patients in NYHA class IV with severe, drug-
refractory, symptoms who are not candidates for CRT, a ventricular assist
device, or cardiac transplantation (because of a very limited life expectancy -
more likely to die from pump failure)
![Page 15: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/15.jpg)
www.escardio.org
15
Recommendation based on 2 (observational) studies with ~2000
ambulatory class IV patients listed for heart transplantation suggested survival benefit with ICD. Sandner SE, Circulation 2001 and Frohlich, Heart 2013
![Page 16: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/16.jpg)
www.escardio.org
Cardiac resynchronization therapy in the primary prevention of sudden death
16
CRT to prevent SCD – Recommendation
Class I for LVEF <35%, LBBB and QRSd > 120 ms.
With LBBB
Without LBBB
Change from ESC HF GL 2012, which only referred to pats with QRS
>150 ms (IIa-A recommendation) and gave no recommendation for
pats with QRS 120-150 ms.
![Page 17: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/17.jpg)
www.escardio.org
![Page 18: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/18.jpg)
www.escardio.org
QRS duration and outcome in CRT studies
18
>150 ms
120-150 ms
Sipahi et al. Arch Intern Med 2011
![Page 19: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/19.jpg)
www.escardio.org
CRT in HF with narrow QRS (<130 ms)
19
Ruschitzka, EchoCRT Study; NEJM 2013
BUT
Females only 30%
Mean QRSd 105 ms
![Page 20: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/20.jpg)
www.escardio.org
Primary outcome events, stratified by QRSd.
Primary composite outcome of death or HF hospitalization in pats randomized to CRT-ON and -OFF, stratified by QRSd.
QRS duration and outcome in CRT studies
Steffel, EchoCRT substudy , EHJ 2015
BUT - Females only 20%
![Page 21: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/21.jpg)
www.escardio.org
![Page 22: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/22.jpg)
www.escardio.org
CRT in HF patients with Atrial Fibrillation
22
This is a slight change from ESC
HF GL 2012, which included
conventional pacing criteria and
had IIa/IIb-C recommendation
irrespective of QRS duration
CRT considered in perm. AF pats if;
1. Ventricular pacing is required or patient otherwise meets CRT criteria
2. Near 100% ventricular pacing achieved with CRT (with ablation or drugs)
![Page 23: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/23.jpg)
www.escardio.org
CRT in the primary prevention of SCD, SR, mild HF
23
Speaker
Upper part is similar to ESC HF GL 2012, but lower part was
IIa-A and is now IIb-A recommendation
MADIT-CRT study; NYHA I-II, LVEF ≤30% QRSd≥ 130 ms.
RAFT trial: NYHA class II-III, LVEF ≤30%, QRSd≥ 120 ms (or paced QRSd≥200 ms).
CRT for prevention of SCD Mild HF, SR, LVEF < 30%, LBBB and QRS d > 130 ms.
![Page 24: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/24.jpg)
www.escardio.org
MADIT-CRT long-term: LBBB vs non-LBBB
24
Goldenberg et al. Long-term survival MADIT-CRT, NEJM 2014
![Page 25: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/25.jpg)
www.escardio.org
Cardiomyopathies
![Page 26: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/26.jpg)
www.escardio.org
1. Dilated cardiomyopathy (DCM)
Secondary
prevention
Primary
prevention
![Page 27: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/27.jpg)
www.escardio.org
2. Hypertrophic cardiomyopathy (HCM)
Life style
SCD Risk
calculator
Secondary
Prevention
NO EPSTUDY
![Page 28: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/28.jpg)
www.escardio.org
![Page 29: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/29.jpg)
www.escardio.org
3. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Secondary
Prevention
Life style
![Page 30: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/30.jpg)
www.escardio.org
3. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Secondary
Prevention
Primary
Prevention
![Page 31: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/31.jpg)
www.escardio.org
VT and VF in structurally normal hearts
![Page 32: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/32.jpg)
www.escardio.org
• VT and VF in structurally normal hearts
• Outflow tract ventricular tachycardia
![Page 33: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/33.jpg)
www.escardio.org
Conclusions
33
Compared to ESC (ACC-AHA) 2006 GL on Management
of VA and Prevention of SCD significant changes are
present.
• Content
• User-friendly format
• Studies needed to better identify pats at higher risk
of death and those who would benefit most of CRT
![Page 34: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/34.jpg)
www.escardio.org
Majority of patients needs cardiac resuscitation
![Page 35: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/35.jpg)
www.escardio.org
Sustained ventricular tachycardia
35
- Catheter ablation
![Page 36: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/36.jpg)
www.escardio.org
Ventricular tachycardias of miscellaneous origin:
- idiopathic LV tachycardia - papillary muscle VT - annular VT (mitral-tricuspid).
![Page 37: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/37.jpg)
www.escardio.orgSipahi et al. Arch Intern Med 2011
QRS duration and outcome in CRT studies
• Meta-regression analysis - impact of QRS d on effect of CRT on events. Each circle = QRS subgroup within a trial. Sizes of circles ~ sample size.
• Dashed line = log risk ratio (RR) of 0 (ie, RR, 1.00) = no net benefit/harm.
• The further circles are below 0 line, the larger the clinical benefit.
Significant relationship between
QRS d at baseline and log RR
(slope, −0.07 [95% CI, −0.10 to
−0.04]; z=−4.60) (P.001).
QRS ranges <150 ms did not
benefit from CRT (black circles,
log risk ratio close to 0). Clinical
benefit appeared when QRSd >
150 ms were included (gray
circles) and became more
prominent with increasing QRS d
(white circles).
![Page 38: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/38.jpg)
www.escardio.org
Bundle branch re-entrant tachycardia
• Bundle branch tachycardia - rare macro-re-entry tachycardia; right bundle branch as anterograde and left bundle branch as retrograde limb.
• 12-lead ECG: LBBB morphology, left-axis deviation.
• Often associated with CMP.
• Catheter ablation of one of bundle branches is curative.
38
![Page 39: Ventricular arrhythmias & sudden cardiac death€¦ · Device therapy-Subcutaneous ICD • Effective in preventing SD. • Data on long-term tolerability and safety are lacking. •](https://reader033.fdocuments.us/reader033/viewer/2022060212/5f051ddd7e708231d4115917/html5/thumbnails/39.jpg)
www.escardio.org
• Device therapy - Public access defibrillator
39